AAA
AGN

Alpine Associates Advisors’s Allergan Inc AGN Stock Holding History

Alpine Associates Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$195K Sell
34,729
-482,971
-93% -$80.2M 0.12% 59
2014
Q2 		$87.6M Buy
+517,700
New +$80.6M 4.06% 6

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Alpine Associates Advisors's AGN Position: Q3 2014 in Review

Alpine Associates Advisors reduced its Allergan Inc (AGN) stake by 93% in Q3 2014, selling an estimated $80.2M and leaving 34,729 shares worth $195K. The position accounts for 0.12% of the portfolio, ranked #59.

Alpine Associates Advisors first reported a position in AGN in Q2 2014 and has held it in 2 quarters since. The position peaked at $87.6M in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Alpine Associates Advisors held 34,729 shares of Allergan Inc worth $195K as of Q3 2014.
  • Alpine Associates Advisors sold 482,971 Allergan Inc shares in Q3 2014, an estimated $80.2M.
  • Allergan Inc made up 0.12% of Alpine Associates Advisors's portfolio in Q3 2014, its #59 holding.
  • Alpine Associates Advisors first reported a position in Allergan Inc in Q2 2014 and has held it in 2 quarters since.
  • Alpine Associates Advisors's Allergan Inc position peaked at $87.6M in Q2 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Alpine Associates Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.